RNA-seq of tumors treated with tumor-derived extracellular vesicle vaccine in orostate cancer mice
This study aims to explore the immunotherapeutic effect of a tumor-derived extracellular vesicle (TEV)-based hydrogel vaccine in a mouse model of prostate cancer. Tumor tissues from treated and control mice were collected for RNA sequencing to identify changes in gene expression related to immune cell recruitment.